SIOPE DIPG网络、登记处与影像库的建立:优化罕见致死性疾病研究的协作努力
DIPG是一种罕见且致命的儿童恶性肿瘤,40年来以单中心、非随机试验为主,生存无改善。2011年在SIOPE脑肿瘤组内建立SIOPE DIPG网络,并开发基于网络的SIOPE DIPG登记处与影像库,截至2016年4月已录入694例患者的临床数据及MR扫描;中位无进展生存期6.0个月(95%CI 5.6-6.4),中位总生存期11.0个月(95%CI 10.5-11.5),诊断后2年和5年生存率分别为10%和2%。
要点
- SIOPE DIPG网络于2011年在欧洲儿科肿瘤学会脑肿瘤组内建立
- SIOPE DIPG登记处与影像库截至2016年4月已录入694例DIPG患者数据
- 中位无进展生存期6.0个月,中位总生存期11.0个月,2年和5年生存率分别为10%和2%
核心结论
- SIOPE DIPG网络和SIOPE DIPG登记处的建立标志着DIPG研究向协作研究转变,被视为理解该疾病、改善诊疗并最终治愈DIPG儿童的必要第一步。
研究设计与样本
- 2011年在欧洲儿科肿瘤学会(SIOPE)脑肿瘤组内建立由生物学家和临床医生组成的SIOPE DIPG网络,并联合信息技术专家和法律顾问开发基于网络的国际综合数据库SIOPE DIPG登记处与影像库,集中收集DIPG患者数据。
主要发现
- 截至2016年4月,694例患者的临床数据及MR扫描已录入SIOPE DIPG登记处/影像库。
- 中位无进展生存期为6.0个月(95%CI 5.6-6.4个月),中位总生存期为11.0个月(95%CI 10.5-11.5个月)。
- 诊断后2年和5年生存率分别为10%和2%。
关键数值与推荐
- 中位无进展生存期6.0个月(95%CI 5.6-6.4个月)。
- 中位总生存期11.0个月(95%CI 10.5-11.5个月)。
- 诊断后2年生存率10%,5年生存率2%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diffuse intrinsic pontine glioma (DIPG) is a rare and deadly childhood malignancy. After 40 years of mostly single-center, often non-randomized trials with variable patient inclusions, there has been no improvement in survival. It is therefore time for international collaboration in DIPG research, to provide new hope for children, parents and medical professionals fighting DIPG. In a first step towards collaboration, in 2011, a network of biologists and clinicians working in the field of DIPG was established within the European Society for Paediatric Oncology (SIOPE) Brain Tumour Group: the SIOPE DIPG Network. By bringing together biomedical professionals and parents as patient representatives, several collaborative DIPG-related projects have been realized. With help from experts in the fields of information technology, and legal advisors, an international, web-based comprehensive database was developed, The SIOPE DIPG Registry and Imaging Repository, to centrally collect data of DIPG patients. As for April 2016, clinical data as well as MR-scans of 694 patients have been entered into the SIOPE DIPG Registry/Imaging Repository. The median progression free survival is 6.0 months (95% Confidence Interval (CI) 5.6-6.4 months) and the median overall survival is 11.0 months (95% CI 10.5-11.5 months). At two and five years post-diagnosis, 10 and 2% of patients are alive, respectively. The establishment of the SIOPE DIPG Network and SIOPE DIPG Registry means a paradigm shift towards collaborative research into DIPG. This is seen as an essential first step towards understanding the disease, improving care and (ultimately) cure for children with DIPG.
引用
- Veldhuijzen van Zanten SEM, Baugh J, Chaney B, et al. Development of the SIOPE DIPG network, registry and imaging repository: a collaborative effort to optimize research into a rare and lethal disease. J Neurooncol. 2017. PMID: 28110411. doi:10.1007/s11060-016-2363-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。